JPH11240832A5 - - Google Patents

Info

Publication number
JPH11240832A5
JPH11240832A5 JP1998290734A JP29073498A JPH11240832A5 JP H11240832 A5 JPH11240832 A5 JP H11240832A5 JP 1998290734 A JP1998290734 A JP 1998290734A JP 29073498 A JP29073498 A JP 29073498A JP H11240832 A5 JPH11240832 A5 JP H11240832A5
Authority
JP
Japan
Prior art keywords
alk
group
optionally substituted
pyrazol
bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998290734A
Other languages
English (en)
Japanese (ja)
Other versions
JP4385414B2 (ja
JPH11240832A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP29073498A priority Critical patent/JP4385414B2/ja
Priority claimed from JP29073498A external-priority patent/JP4385414B2/ja
Publication of JPH11240832A publication Critical patent/JPH11240832A/ja
Publication of JPH11240832A5 publication Critical patent/JPH11240832A5/ja
Application granted granted Critical
Publication of JP4385414B2 publication Critical patent/JP4385414B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP29073498A 1997-10-13 1998-10-13 アミド若しくはアミン誘導体 Expired - Lifetime JP4385414B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29073498A JP4385414B2 (ja) 1997-10-13 1998-10-13 アミド若しくはアミン誘導体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP27909397 1997-10-13
JP9-279093 1997-10-13
JP29073498A JP4385414B2 (ja) 1997-10-13 1998-10-13 アミド若しくはアミン誘導体

Publications (3)

Publication Number Publication Date
JPH11240832A JPH11240832A (ja) 1999-09-07
JPH11240832A5 true JPH11240832A5 (enExample) 2005-04-21
JP4385414B2 JP4385414B2 (ja) 2009-12-16

Family

ID=26553175

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29073498A Expired - Lifetime JP4385414B2 (ja) 1997-10-13 1998-10-13 アミド若しくはアミン誘導体

Country Status (1)

Country Link
JP (1) JP4385414B2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506747B1 (en) * 1998-06-05 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
ATE467620T1 (de) * 1999-03-26 2010-05-15 Euro Celtique Sa Arylsubstituierte pyrazole, imidazole, oxazole, thiazole und pyrrole, sowie deren verwendung
CN1321112C (zh) * 2000-03-24 2007-06-13 欧洲凯尔特股份有限公司 作为钠通道阻滞剂的芳基取代的吡唑、三唑和四唑化合物
JP4083422B2 (ja) * 2000-12-22 2008-04-30 石原産業株式会社 アニリン誘導体またはその塩ならびにそれらを含有するサイトカイン産生抑制剤
CN1930144A (zh) * 2004-03-09 2007-03-14 贝林格尔·英格海姆药物公司 可用作细胞因子产生抑制剂用于治疗慢性炎性疾病的3,4’－杂环基－1,2,3－三唑－1－基－n－芳基苯甲酰胺
US8802721B2 (en) 2005-01-25 2014-08-12 Synta Pharmaceuticals Corp. Thiophene compounds for inflammation and immune-related uses
KR101436161B1 (ko) 2005-01-25 2014-09-01 신타 파마슈티칼스 코프. 염증 및 면역 관련 용도를 위한 화합물
WO2007100851A1 (en) * 2006-02-28 2007-09-07 Helicon Therapeutics, Inc. Therapeutic compounds
US8779154B2 (en) * 2006-09-26 2014-07-15 Qinglin Che Fused ring compounds for inflammation and immune-related uses
JP5718053B2 (ja) 2007-08-27 2015-05-13 ヘリコン・セラピューティクス・インコーポレーテッド 治療用イソオキサゾール化合物
EP2421835A1 (en) * 2009-04-24 2012-02-29 Glaxo Group Limited N-pyrazolyl carboxamides as crac channel inhibitors
US8993612B2 (en) * 2009-10-08 2015-03-31 Rhizen Pharmaceuticals Sa Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
US8377970B2 (en) * 2009-10-08 2013-02-19 Rhizen Pharmaceuticals Sa Modulators of calcium release-activated calcium channel
CA2797533A1 (en) 2010-04-27 2011-11-10 Calcimedica, Inc. Compounds that modulate intracellular calcium

Similar Documents

Publication Publication Date Title
JPH11240832A5 (enExample)
JP2005536458A5 (enExample)
US6348480B1 (en) Pharmaceutical compound comprising a pyrazole derivative and methods of using the same for the treatment of calcium release-activated calcium channel associated diseases
CA2483159A1 (en) Triazole derivatives as tachykinin receptor antagonists
US8822451B2 (en) Modulators of ATP-binding cassette transporters
US8324216B2 (en) Substituted piperazines
US20090018104A1 (en) Triarylcarboxylic Acid Derivative
CA2496139A1 (en) Benzimidazole derivatives
JP2006514942A5 (enExample)
JP2009523812A5 (enExample)
CA2484188A1 (en) Tachykinin receptor antagonists
JP2020516671A5 (enExample)
JP2002520323A5 (enExample)
US20180214418A1 (en) Multisubstituted aromatic compounds as inhibitors of thrombin
JP2010513438A5 (enExample)
JP2010513435A5 (enExample)
EP1438973A1 (en) Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
JP2010275317A5 (enExample)
JP2006500348A5 (enExample)
JP2002536329A5 (enExample)
JP2007504161A5 (enExample)
JP2008510828A5 (enExample)
JP2006501273A5 (enExample)
JP2010502717A5 (enExample)
JP2006504761A5 (enExample)